Heart drug carvedilol studied for Parkinson's clues in small trial
NCT ID NCT04218968
First seen Mar 11, 2026 · Last updated Apr 29, 2026 · Updated 6 times
Summary
This study looks at how carvedilol, a medicine used for heart conditions, changes brain scans over three years in 15 people who have early signs that may lead to Parkinson's disease. Participants have REM sleep behavior disorder and other risk factors. The goal is to learn more about how Parkinson's develops, not to test a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REM SLEEP BEHAVIOR DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Michele L Lima Gregorio
Los Angeles, California, 90046, United States
Conditions
Explore the condition pages connected to this study.